Agilent Acquires Artificial Intelligence Technology to Improve Lab Productivity


SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE:A) today announced the acquisition of advanced artificial intelligence (AI) technology developed by Virtual Control, an AI and machine learning software developer that creates innovative analytical solutions for laboratory testing. Agilent will integrate the software, known as ACIES, into its industry-leading gas chromatography and mass spectrometry (GS/MS) platforms to improve productivity, efficiency and precision from the high-throughput labs the company serves around the world.

With the acquisition, Agilent obtained the software and other associated assets from ACIES. As part of the transaction, key members of the ACIES team also became Agilent employees.

ACIES automates the tedious task of gas chromatography/mass spectrometry data analysis, improving the efficiency of laboratory workflow from sampling to reporting. Agilent will integrate the technology into its MassHunter software package for LC/MS and GC/MS instruments.

“Our acquisition of this cutting-edge technology is just one more example of Agilent’s focus on providing insights and innovations that our customers can use to deliver cutting-edge solutions,” said Jacob. Thaysen, president, Agilent Life Sciences and Applied Markets Group. “We are extremely pleased to add these additional features to our product line.”

A range of industries and applications will benefit from Agilent’s acquisition of the technology, including food testing and agriculture, environment and applied materials, with broad potential for expansion into other major markets.

This acquisition is Agilent’s latest investment in digital technology to improve laboratory productivity. It builds on the company’s existing investments and innovations to advance the analytical lab and transform its capabilities with new technologies, better instrument and data integration, and more efficient lab workflow.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics and applied chemicals markets, delivering insights and innovations that improve the quality of life. Agilent’s comprehensive portfolio of solutions includes instruments, software, services, and expertise that provide reliable answers to our customers’ toughest questions. The company generated $6.32 billion in revenue in fiscal 2021 and employs 17,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter and Facebook.

Forward-looking statements

This press release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. Forward-looking statements contained herein include, but are not limited to, statements regarding the capabilities brought about by the acquisition and future uses of the assets. These forward-looking statements involve risks and uncertainties that could cause Agilent’s results to differ materially from management’s current expectations. These risks and uncertainties include, but are not limited to, the ability to retain key employees and meet customer expectations. In addition, other risks Agilent faces in managing its operations include the ability to execute successfully through economic cycles; the ability to achieve and realize the benefits of its cost reduction objectives and successfully adapt its cost structures to continually changing business conditions; ongoing competitive, pricing and gross margin pressures; the risk that our cost reduction initiatives impair our ability to develop products, remain competitive and operate effectively; the impact of geopolitical uncertainties and global economic conditions on our business, markets and ability to do business; the ability to improve asset performance to adapt to changes in demand; the ability of our supply chain to adapt to changes in demand; the ability to successfully introduce new products at the right time, at the right price and in the right mix; Agilent’s ability to successfully integrate recent acquisitions; Agilent’s ability to successfully comply with certain complex regulations; and other risks detailed in Agilent’s filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended October 31, 2021. Forward-looking statements are based on beliefs and Agilent management’s assumptions and information currently available. Agilent disclaims any responsibility to publicly update or revise any forward-looking statement.

Previous State public libraries need more financial support
Next More than 200 healthcare organizations ask HHS to keep direct contracts